Skip to main content

LA MICROBIOTA DE LA BILIS HUMANA: ECOLOGIA, FUNCIONALIDAD Y RELACION CON LA DIETA Y ALGUNOS TRASTORNOS BILIARES

AGL2013-44761-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

In silico and functional analyses of immunomodulatory peptides encrypted in the human gut metaproteome

  • Cambeiro Pérez, Noelia
  • Hidalgo Cantabrana, Claudio
  • Moro García, Marco Antonio
  • Blanco Míguez, Aitor
  • Fernández Riverola, Florentino
  • Riestra, Sabino
  • GARCIA LOURENÇO, Analia Maria
  • Alonso Arias, Rebeca
  • Margolles, Abelardo
  • Martínez Carballo, Elena
  • Sanchez Garcia, Borja
This work supports the massive presence of potential immunomodulatory peptides in the human gut metaproteome. These peptides were identified through the MAHMI database as potentially anti-inflammatory, and sixteen of them synthesized for characterize their mechanism of action. From them, peptide HM14 was encrypted in an extracellular protein produced by Bifidobacterium longum, a common member of the human microbiota, and displayed the highest anti-inflammatory capability. Molecular mechanism of action of HM14 pointed to a specific interaction between this immunomodulatory peptide and antigen presenting cells, which resulted in a higher formation of iTreg cells. Moreover, HM14 was effective in decreasing pro-inflammatory parameters in PBMCs isolated from a cohort of Crohn's patients. Finally, non-targeted metabolomics confirmed the ability of HM14 to modulate the metabolic activity of PBMCs to fulfil its energy and biosynthetic requirements. Overall, our combined in silico/multiomics approach supports the human gut metaproteome as a source for immunomodulatory peptides., Ministerio de Economía y Competitividad | Ref. AGL2013-44761-P, Agencia Estatal de Investigación | Ref. AGL2016-78311-R
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Diet: Cause or Consequence of the Microbial Profile of Cholelithiasis Disease?

  • Gutiérrez-Díaz, Isabel
  • Molinero, Natalia
  • Cabrera, Ana
  • Rodríguez García, José Ignacio
  • Margolles Barros, Abelardo
  • Delgado, Susana
  • González Solares, Sonia
Recent dietary habits and lifestyle could explain the shaping of the gut microbiota composition and, in consequence, the increasing prevalence of certain pathologies. However, little attention has been paid to the influence of diet on microbiotas, other than the gut microbiota. This is important in cholelithiasis, given that changes in the production of bile acids may affect gallbladder microbial communities. Our aim was to assess the association between regular dietary intake and gallbladder microbial composition. Fourteen adults with cholelithiasis and 14 controls, sex-age-matched and without gastrointestinal pathology, were included. Diet was assessed through a food frequency questionnaire and quantification of gallbladder microbiota sequences by Illumina 16S rRNA gene-based analysis. The cholelithiasic patients showed greater intake of potatoes and lower consumption of vegetables, non-alcoholic drinks, and sauces, which resulted in a lower intake of energy, lipids, digestible polysaccharides, folate, calcium, magnesium, vitamin C, and some phenolic compounds. Regarding the altered bile microorganisms in cholelithiasic patients, dairy product intake was negatively associated with the proportions of Bacteroidaceae and Bacteroides, and several types of fiber, phenolics, and fatty acids were linked to the abundance of Bacteroidaceae, Chitinophagaceae, Propionibacteraceae, Bacteroides, and Escherichia-Shigella. These results support a link between diet, biliary microbiota, and cholelithiasis., This research was funded by the Spanish “Plan Estatal de I+D+i” Grant number (AGL2013-44761-P) I. Gutiérrez-Díaz was supported by “Plan Regional de Investigación del Principado de Asturias” Grant number (GRUPIN14-043)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases

  • Serrano-Villar, Sergio
  • Rojo, David
  • Martínez-Martínez, Mónica
  • Deusch, Simon
  • Vázquez-Castellanos, Jorge F.
  • Sainz, Talia
  • Vera, Mar
  • Moreno, Santiago
  • Estrada, Vicente
  • Gosalbes, María José
  • Latorre, Amparo
  • Margolles Barros, Abelardo
  • Seifert, Jana
  • Barbas, Coral
  • Moya, Andrés
  • Ferrer, Manuel
Imbalances in gut bacteria have been associated with multiple diseases. However, whether there are disease-specific changes in gut microbial metabolism remains unknown. Here, we demonstrate that human immunodeficiency virus (HIV) infection (n=33) changes, at quantifiable levels, the metabolism of gut bacteria. These changes are different than those observed in patients with the auto-immune disease systemic lupus erythaematosus (n=18), and Clostridium difficile-associated diarrhoea (n=6). Using healthy controls as a baseline (n=16), we demonstrate that a trend in the nature and directionality of the metabolic changes exists according to the type of the disease. The impact on the gut microbial activity, and thus the metabolite composition and metabolic flux of gut microbes, is therefore disease-dependent. Our data further provide experimental evidence that HIV infection drastically changed the microbial community, and the species responsible for the metabolism of 4 amino acids, in contrast to patients with the other two diseases and healthy controls. The identification in this present work of specific metabolic deficits in HIV-infected patients may define nutritional supplements to improve the health of these patients., This work was supported by the Health Research Institute of University Hospital Clínico San Carlos, “Generalitat Valenciana” (PROMETEOII/2014/065), by the Spanish Ministry of Economy and Competitiveness (SAF2012-31187, SAF2013-49788-EXP, SAF2015-65878 and AGL2013-44761-P), Instituto de Salud Carlos III (PIE14-00045 and Redes Temáticas de Investigación en SIDA RETIC RD12/0017/0029 and RD12/0017/0037), and the Junta de Andalucía (Proyecto de Excelencia CTS-6313). The present investigation was also funded by the Spanish Ministry of Economy and Competitiveness and the Federal Ministry of Education and Research (BMBF) within the ERA NET PathoGenoMics2 program, grant number 0315441A. This work was further funded by grants BIO2011-25012, BIO2014-54494-R from the Spanish Ministry of Economy and Competitiveness. The authors gratefully acknowledge the financial support provided by the European Regional Development Fund (ERDF). C.B and D.R would like to acknowledge funding from the Spanish Ministry of Economy and Competitiveness (CTQ2014-55279-R). J.F.V.C. was supported by a fellowship ‘‘Ayudas Predoctorales de Formación en Investigación en Salud” from the Instituto de Salud Carlos III (Spain) and a fellowship from CONACYT-SECITI (México). S.S.-V. is supported by a grant from the Spanish Ministry of Science and Innovation (Contratos Juan Rodés, ECC/1051/2013), and T.S. is supported by a grant from the European Society of Paediatric Infectious Diseases (ESPID), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bifidobacteria and their health-promoting effects

  • Hidalgo-Cantabrana, Claudio
  • Delgado, Susana
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting effects. The genus Bifidobacterium belongs to the Actinobacteria phylum. Firmicutes, Bacteroidetes, and Actinobacteria constitute the most abundant phyla in the human intestinal microbiota, Firmicutes and Bacteroidetes being predominant in adults, and Actinobacteria in breast-fed infants, where bifidobacteria can reach levels higher than 90% of the total bacterial population. They are among the first microbial colonizers of the intestines of newborns, and play key roles in the development of their physiology, including maturation of the immune system and use of dietary components. Indeed, some nutrients, such as human milk oligosaccharides, are important drivers of bifidobacterial development. Some Bifidobacterium strains are considered probiotic microorganisms because of their beneficial effects, and they have been included as bioactive ingredients in functional foods, mainly dairy products, as well as in food supplements and pharma products, alone, or together with, other microbes or microbial substrates. Well-documented scientific evidence of their activities is currently available for bifidobacteria-containing preparations in some intestinal and extraintestinal pathologies. In this review, we focus on the role of bifidobacteria as members of the human intestinal microbiota and their use as probiotics in the prevention and treatment of disease., Research in our group is supported by grants AGL2015- 64901-R, BIO2014-55019-JIN, AGL2013-44761-P, and AGL2013-44039-R from the Spanish Ministry of Economy and Competitiveness, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile

  • Molinero, Natalia
  • Ruíz García, Lorena
  • Milani, Christian
  • Gutiérrez-Díaz, Isabel
  • Sánchez García, Borja
  • Mangifesta, Marta
  • Segura, José
  • Cambero, Isabel
  • Campelo, Ana B.
  • García-Bernardo, Carmen M.
  • Cabrera, Ana
  • Rodríguez, José I.
  • González Solares, Sonia
  • Rodríguez, Juan M.
  • Ventura, Marco
  • Delgado, Susana
  • Margolles Barros, Abelardo
[Background] The microbial populations of the human intestinal tract and their relationship to specific diseases have been extensively studied during the last decade. However, the characterization of the human bile microbiota as a whole has been hampered by difficulties in accessing biological samples and the lack of adequate methodologies to assess molecular studies. Although a few reports have described the biliary microbiota in some hepatobiliary diseases, the bile microbiota of healthy individuals has not been described. With this in mind, the goal of the present study was to generate fundamental knowledge on the composition and activity of the human bile microbiota, as well as establishing its potential relationship with human bile-related disorders., [Results] Human bile samples from the gallbladder of individuals from a control group, without any record of hepatobiliary disorder, were obtained from liver donors during liver transplantation surgery. A bile DNA extraction method was optimized together with a quantitative PCR (qPCR) assay for determining the bacterial load. This allows the selection of samples to perform functional metagenomic analysis. Bile samples from the gallbladder of individuals suffering from lithiasis were collected during gallbladder resection and the microbial profiles assessed, using a 16S rRNA gene-based sequencing analysis, and compared with those of the control group. Additionally, the metabolic profile of the samples was analyzed by nuclear magnetic resonance (NMR). We detected, for the first time, bacterial communities in gallbladder samples of individuals without any hepatobiliary pathology. In the biliary microecosystem, the main bacterial phyla were represented by Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. Significant differences in the relative abundance of different taxa of both groups were found. Sequences belonging to the family Propionibacteriaceae were more abundant in bile samples from control subjects; meanwhile, in patients with cholelithiasis members of the families Bacteroidaceae, Prevotellaceae, Porphyromonadaceae, and Veillonellaceae were more frequently detected. Furthermore, the metabolomics analysis showed that the two study groups have different metabolic profiles., [Conclusions] Our results indicate that the gallbladder of human individuals, without diagnosed hepatobiliary pathology, harbors a microbial ecosystem that is described for the first time in this study. Its bacterial representatives and metabolites are different from those detected in people suffering from cholelithiasis. In this regard, since liver donors have been subjected to the specific conditions of the hospital’s intensive care unit, including an antibiotic treatment, we must be cautious in stating that their bile samples contain a physiologically normal biliary microbiome. In any case, our results open up new possibilities to discover bacterial functions in a microbial ecosystem that has not previously been explored., The study was supported by MINECO under grant number AGL2013-44761-P. Lorena Ruiz is a postdoctoral researcher supported by the Juan de la Cierva Postdoctoral Trainee Program (IJCI-2015-23196), and Natalia Molinero is the recipient of an FPI Predoctoral Grant (BES-2014-068736)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Probiotics, gut microbiota, and their influence on host health and disease

  • Sánchez García, Borja
  • Delgado, Susana
  • Blanco-Míguez, Aitor
  • Lourenço, Anália
  • Gueimonde Fernández, Miguel
  • Margolles Barros, Abelardo
The gastrointestinal tract of mammals hosts a high and diverse number of different microorganisms, known as intestinal microbiota. Many probiotics were originally isolated from the gastrointestinal tract, and they were defined by the Food and Agriculture Organization of the United Nations (FAO)/WHO as “live microorganisms which when administered in adequate amounts confer a health benefit on the host.” Probiotics exert their beneficial effects on the host through four main mechanisms: interference with potential pathogens, improvement of barrier function, immunomodulation and production of neurotransmitters, and their host targets vary from the resident microbiota to cellular components of the gut–brain axis. However, in spite of the wide array of beneficial mechanisms deployed by probiotic bacteria, relatively few effects have been supported by clinical data. In this regard, different probiotic strains have been effective in antibiotic‐associated diarrhea or inflammatory bowel disease for instance. The aim of this review was to compile the molecular mechanisms underlying the beneficial effects of probiotics, mainly through their interaction with the intestinal microbiota and with the intestinal mucosa. The specific benefits discussed in this paper include among others those elicited directly through dietary modulation of the human gut microbiota., Research in our lab is funded by Grants AGL2013‐44039‐R and AGL2013‐44761‐P from the Spanish “Plan Estatal de I+D+I.” Part of the authors is also partially funded by the [15VI013] Contract‐Programme from the University of Vigo and the Agrupamento INBIOMED from DXPCTSUG‐FEDER unha maneira de facer Europa (2012/273). B. S. was recipient of a Ramón y Cajal postdoctoral contract from the Spanish Ministry of Economy and Competitiveness., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Detección y cuantificación por qPCR del ADN microbiano total en muestras de bilis humanas como paso previo a estudios del microbioma biliar

  • Molinero, Natalia
  • Campelo, Ana B.
  • García Bernardo, Carmen
  • Rodríguez, José Ignacio
  • Margolles Barros, Abelardo
  • Delgado, Susana
Trabajo presentado en la X Reunión de la Red Española de Bacterias Lácticas, celebrada en Madrid el 23 y 24 de Junio de 2016, En los últimos años se está poniendo de manifiesto más claramente la relación entre el metabolismo de sales biliares y el colesterol y la microbiota del tracto gastrointestinal (TGI), así como sus posibles implicaciones en la salud. A diferencia de otras localizaciones del TGI, el microbioma de la bilis y el tracto biliar apenas han sido estudiados, debido principalmente a la limitación para acceder al material biológico y la dificultad de obtener ADN de calidad entre otros. En este trabajo se ha optimizado un protocolo de extracción y purificación de ADN total de bilis humana, y se ha desarrollado un método de discriminación y cuantificación de ADN microbiano basado en PCR cuantitativa (qPCR), para seleccionar aquellas muestras de bilis con mayor carga microbiana con el objetivo de caracterizar el microbioma biliar mediante ultrasecuenciación del ADN total y realizar un análisis metagenómico funcional. Se extrajo el ADN de muestras de 1ml de bilis, de 22 sujetos sanos y 12 pacientes con colelitiasis. El método se basó en el descrito por Moles y cols. (2013) con ligeras modificaciones. Para la discriminación del ADN microbiano y eucariota el ADN total extraído se cuantificó por qPCR utilizando cebadores universales para el gen del ARNr 16S y el gen del ARNr 18S, utilizando rectas patrón a partir de la cepa Lactococcus lactis NZ9000 y de la línea celular HT-29. Por otro lado, se enriquecieron muestras de bilis con diluciones decimales de concentración conocida de L. lactis NZ9000 (rango 108-103 ufc/ml) para determinar la eficiencia del método y testar el efecto matriz. El enriquecimiento con la cepa de L. lactis de las muestras de bilis nos permitió comprobar que la metodología era eficaz para cuantificar ADN microbiano en concentraciones superiores a 102 células procariotas/ml, mostrando mayor eficiencia en el rango 103-106. Las muestras de bilis humana de sujetos sanos, exceptuando una de ellas, mostraron niveles de 102-103 equivalentes genómicos/ml (cercanos al límite de detección de la técnica establecido). Las muestras de pacientes con colelitiasis mostraron mayores diferencias entre sí, y en algunos casos presentaron niveles en torno a 103 y 104 equivalentes genómicos/ml. En ambos casos el método desarrollado reveló la presencia de ADN eucariota en bilis humana en ordenes mayores (~106 equivalentes genómicos/ml), lo que a priori puede dificultar el acceso al análisis del microbioma. El método nos ha permitido seleccionar las muestras con mayor concentración de ADN microbiano, en las que mediante secuenciación masiva del ADN total hemos podido acceder a cerca de un 30% de secuencias de calidad de origen no humano para caracterizar y describir desde el punto de vista taxonómico y funcional el ecosistema microbiano biliar., AGL2013-44761-P, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile

  • Molinero, Natalia
  • Gutiérrez-Díaz, Isabel
  • Milani, Christian
  • Ruíz García, Lorena
  • Sánchez García, Borja
  • Mangifesta, Marta
  • Cambero, Isabel
  • Campelo, Ana B.
  • García-Bernardo, Carmen M.
  • Cabrera, Ana
  • Rodríguez, José Ignacio
  • González Solares, Sonia
  • Rodríguez, Juan Miguel
  • Ventura, Marco
  • Delgado, Susana
  • Margolles Barros, Abelardo
Trabajo presentado en la 12ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Sevilla (España) del 17 al 18 de mayo de 2018., Y presentado también en el 7th International Human Microbiome Congress, IHMC, celebrado en County Kerry (Irlanda) del 28 al 26 de junio de 2018, n los últimos años se está revelando la relación entre el metabolismo de sales biliares y el colesterol, la microbiota intestinal y su implicación en la salud. A diferencia de otras localizaciones, el microbioma del tracto biliar apenas ha sido estudiado. En este trabajo se ha realizado un análisis metagenómico filogenético y funcional de muestras de bilis humana, además de un análisis metabolómico, con el fin de caracterizar el microbioma biliar de donantes de hígado y pacientes con colelitiasis, e identificar posibles disbiosis asociadas a esta patología. Se obtuvieron muestras de bilis de donantes de hígado y pacientes con colelitiasis, de las que se extrajo el ADN biliar siguiendo un protocolo optimizado. Se llevó a cabo la secuenciación masiva de amplicones del ADNr 16S mediante la tecnología Illumina. Además, se realizó secuenciación masiva por shotgun y análisis de metagenómica funcional de tres muestras de bilis de sujetos sanos. El análisis metabolómico se realizó utilizando técnicas de NMR. Los resultados mostraron una gran diversidad microbiana presente en este tipo de muestras, con presencia de 4 filos mayoritarios: Firmicutes, Bacteriodetes, Actinobacteria y Proteobacteria. El análisis estadístico mostró diferencias significativas en la abundancia relativa de diversos taxones presentes en la bilis de ambos grupos. En concreto, secuencias de la familia Propionibacteriaceae fueron más abundantes en la bilis de los donantes de hígado, mientras que en pacientes con colelitiasis fueron más frecuentes las de las familias Bacteroidaceae, Prevotellaceae, Porphyromonadaceae y Veillonellaceae. El análisis funcional mostró que la asignación a las principales categorías funcionales del COG es similar a la del microbioma intestinal humano. Por último, el análisis metabolómico nos permitió asociar diferentes perfiles metabólicos a los grupos de individuos objeto de estudio., This work was financed by the Spanish “Plan Nacional I+D+i” through the project AGL2013-44761-P, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intestinal bacteria interplay with bile and cholesterol metabolism: Implications on host physiology

  • Molinero, Natalia
  • Ruíz García, Lorena
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
  • Delgado, Susana
Bile is a biological fluid synthesized in the liver, mainly constituted by bile acids and cholesterol, which functions as a biological detergent that emulsifies and solubilizes lipids, thereby playing an essential role in fat digestion. Besides, bile acids are important signaling molecules that regulate key functions at intestinal and systemic levels in the human body, affecting glucose and lipid metabolism, and immune homeostasis. Apart from this, due to their amphipathic nature, bile acids are toxic for bacterial cells and, thus, exert a strong selective pressure on the microbial populations inhabiting the human gut, decisively shaping the microbial profiles of our gut microbiota, which has been recognized as a metabolic organ playing a pivotal role in host health. Remarkably, bacteria in our gut also display a range of enzymatic activities capable of acting on bile acids and, to a lesser extent, cholesterol. These activities can have a direct impact on host physiology as they influence the composition of the intestinal and circulating bile acid pool in the host, affecting bile homeostasis. Given that bile acids are important signaling molecules in the human body, changes in the microbiota-residing bile biotransformation ability can significantly impact host physiology and health status. Elucidating ways to fine-tune microbiota-bile acids-host interplay are promising strategies to act on bile and cholesterol-related disorders. This manuscript summarizes the current knowledge on bile and cholesterol metabolism by intestinal bacteria, as well as its influence on host physiology, identifying knowledge gaps and opportunities to guide further advances in the field., This study was supported by MINECO under grant number AGL2013-44761-P. LR is a postdoctoral researcher supported by the Juan de la Cierva Postdoctoral Trainee Program (MINECO, JCI-2015-23196) and NM is the recipient of an FPI Predoctoral Grant (BES-2014-068736).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Functional characterisation of bile metagenome: Study of metagenomic dark matter

  • Sabater, Carlos
  • Molinero, Natalia
  • Ferrer, Manuel
  • García Bernardo, Carmen María
  • Delgado, Susana
  • Margolles Barros, Abelardo
This article belongs to the Special Issue Microbial Impact on Cholesterol and Bile Acid Metabolism., Gallbladder metagenome involves a wide range of unidentified sequences comprising the so-called metagenomic dark matter. Therefore, this study aimed to characterise three gallbladder metagenomes and a fosmid library with an emphasis on metagenomic dark matter fraction. For this purpose, a novel data analysis strategy based on the combination of remote homology and molecular modelling has been proposed. According to the results obtained, several protein functional domains were annotated in the metagenomic dark matter fraction including acetyltransferases, outer membrane transporter proteins, membrane assembly factors, DNA repair and recombination proteins and response regulator phosphatases. In addition, one deacetylase involved in mycothiol biosynthesis was found in the metagenomic dark matter fraction of the fosmid library. This enzyme may exert a protective effect in Actinobacteria against bile components exposure, in agreement with the presence of multiple antibiotic and multidrug resistance genes. Potential mechanisms of action of this novel deacetylase were elucidated by molecular simulations, highlighting the role of histidine and aspartic acid residues. Computational pipelines presented in this work may be of special interest to discover novel microbial enzymes which had not been previously characterised., This study was supported by MINECO (Spanish Ministry of Economy and Competitiveness) under grant number AGL2013-44761-P, supported by FEDER (The European Regional Development Funds). NM was the recipient of an FPI Predoctoral Grant (BES-2014-068736) from MINECO. CS is a postdoctoral researcher supported by the Juan de la Cierva-Formación Postdoctoral Trainee Program from MICINN, the Spanish Ministry of Science and Innovation (FJC2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ruminococcoides bili gen. Nov., sp. nov., a bile-resistant bacterium from human bile with autolytic behavior

  • Molinero, Natalia
  • Conti, Elena
  • Sánchez García, Borja
  • Walker, Alan W.
  • Margolles Barros, Abelardo
  • Duncan, Sylvia H.
  • Delgado, Susana
A strictly anaerobic, resistant starch-degrading, bile-tolerant, autolytic strain, IPLA60002, belonging to the family Ruminococcaceae, was isolated from a human bile sample of a liver donor without hepatobiliary disease. Cells were Gram-stain-positive cocci, and 16S rRNA gene and whole genome analyses showed that Ruminococcus bromii was the phylogenetically closest related species to the novel strain IPLA60002, though with average nucleotide identity values below 90%. Biochemically, the new isolate has metabolic features similar to those described previously for gut R. bromii strains, including the ability to degrade a range of different starches. The new isolate, however, produces lactate and shows distinct resistance to the presence of bile salts. Additionally, the novel bile isolate displays an autolytic phenotype after growing in different media. Strain IPLA60002 is phylogenetically distinct from other species within the genus Ruminococcus. Therefore, we propose on the basis of phylogenetic, genomic and metabolic data that the novel IPLA60002 strain isolated from human bile be given the name Ruminococcoides bili gen. nov., sp. nov., within the new proposed genus Ruminococcoides and the family Ruminococcaceae. Strain IPLA60002 (=DSM 110008=LMG 31505) is proposed as the type strain of Ruminococcoides bili., This study was supported by the: Tenovus (GB) Principle Award Recipient: ElenaConti Rural and Environment Science and Analytical Services Division (GB) (Award SG-RESAS) Principle Award Recipient: SylviaH. Duncan Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología (Award IDI/2018/000236) Principle Award Recipient: NotApplicable Ministerio de Economía y Competitividad (Award Ramón y Cajal” program (RYC-2016-19726)) Principle Award Recipient: SusanaDelgado Ministerio de Economía y Competitividad (Award FPI Predoctoral Grant BES-2014-068736) Principle Award Recipient: NataliaMolinero Ministerio de Economía y Competitividad (Award AGL2013-44761-P) Principle Award Recipient: AbelardoMargolles
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Survival Strategies and Metabolic Interactions between Ruminococcus gauvreauii and Ruminococcoides bili, Isolated from Human Bile

  • Molinero, Natalia
  • Conti, Elena
  • Walker, Alan W.
  • Margolles Barros, Abelardo
  • Duncan, Sylvia H.
  • Delgado, Susana
Little is known about the bacteria that reside in the human gallbladder and the mechanisms that allow them to survive within this harsh environment. Here we describe interactions between two strains from a human bile sample, one Ruminococcus gauvreauii (IPLA60001), belonging to the Lachnospiraceae family, and the other, designated as Ruminococcoides bili (IPLA60002; DSM 110008) most closely related to Ruminococcus bromii within the family Ruminococcaceae. We provide evidence for bile salt resistance and sporulation for these new strains. Both differed markedly in their carbohydrate metabolism. The R. bili strain mainly metabolized resistant starches to form formate, lactate and acetate. R. gauvreauii mainly metabolized sugar alcohols, including inositol and also utilized formate to generate acetate employing the Wood Ljungdahl pathway. Amino acid and vitamin biosynthesis genomic profiles also differed markedly between the two isolates, likely contributing to their synergistic interactions, as revealed by transcriptomic analysis of cocultures. Transcriptome analysis also revealed that R. gauvreauii IPLA60001 is able to grow using the end-products of starch metabolism formed by the R. bili strain such as formate, and potentially other compounds (such as ethanolamine and inositol) possibly provided by the autolytic behavior of R. bili., This work was funded by MINECO (Spanish Ministry of Economy and Competitiveness) under grant number AGL2013-44761-P, supported by FEDER (The European Regional Development Funds). N.M. was the recipient of an FPI Predoctoral Grant (BES-2014-068736) from MINECO. A.M. thanks the support of CSIC (PIE-201970E019 grant). N.M., A.M., and S.D. from the MicroHealth group would like to thank the grant of the “Plan for Research, Development and Innovation of the Principado de Asturias 2018–2020” (ref. IDI/2018/000236) co-financed by FEDER funds. S.H.D. and A.W.W. acknowledge core funding support for the Rowett Institute from the Scottish Government Rural and Environmental Sciences and Analytical Services (RESAS) as well as the support for E.C. from the Tenovus Charitable trust (Scotland). Donna Henderson from Rowett Institute (University of Aberdeen) is also acknowledged for carrying out the gas chromatography analysis.